FTC, drug company agree: Divest two products
To obtain FTC approval for a deal, a British pharmaceutical company has consented to divest two injectable drugs, preserving competition in the United States pharmaceutical market.
In October 2010, Hikma Pharmaceuticals...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login
to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information:
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch